Cargando…

Nuclear hBD-1 accumulation in malignant salivary gland tumours

BACKGROUND: Whereas the antimicrobial peptides hBD-2 and -3 are related to inflammation, the constitutively expressed hBD-1 might function as 8p tumour suppressor gene and thus play a key role in control of transcription and induction of apoptosis in malignant epithelial tumours. Therefore this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wenghoefer, M, Pantelis, A, Dommisch, H, Götz, W, Reich, R, Bergé, S, Martini, M, Allam, JP, Jepsen, S, Merkelbach-Bruse, S, Fischer, HP, Novak, N, Winter, J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567991/
https://www.ncbi.nlm.nih.gov/pubmed/18840281
http://dx.doi.org/10.1186/1471-2407-8-290
_version_ 1782160024524554240
author Wenghoefer, M
Pantelis, A
Dommisch, H
Götz, W
Reich, R
Bergé, S
Martini, M
Allam, JP
Jepsen, S
Merkelbach-Bruse, S
Fischer, HP
Novak, N
Winter, J
author_facet Wenghoefer, M
Pantelis, A
Dommisch, H
Götz, W
Reich, R
Bergé, S
Martini, M
Allam, JP
Jepsen, S
Merkelbach-Bruse, S
Fischer, HP
Novak, N
Winter, J
author_sort Wenghoefer, M
collection PubMed
description BACKGROUND: Whereas the antimicrobial peptides hBD-2 and -3 are related to inflammation, the constitutively expressed hBD-1 might function as 8p tumour suppressor gene and thus play a key role in control of transcription and induction of apoptosis in malignant epithelial tumours. Therefore this study was conducted to characterise proteins involved in cell cycle control and host defence in different benign and malignant salivary gland tumours in comparison with healthy salivary gland tissue. METHODS: 21 paraffin-embedded tissue samples of benign (n = 7), and malignant (n = 7) salivary gland tumours as well as healthy (n = 7) salivary glands were examined immunohistochemically for the expression of p53, bcl-2, and hBD-1, -2, -3. RESULTS: HBD-1 was distributed in the cytoplasm of healthy salivary glands and benign salivary gland tumours but seems to migrate into the nucleus of malignant salivary gland tumours. Pleomorphic adenomas showed cytoplasmic as well as weak nuclear hBD-1 staining. CONCLUSION: HBD-1, 2 and 3 are traceable in healthy salivary gland tissue as well as in benign and malignant salivary gland tumours. As hBD-1 is shifted from the cytoplasm to the nucleus in malignant salivary gland tumours, we hypothesize that it might play a role in the oncogenesis of these tumours. In pleomorphic adenomas hBD-1 might be connected to their biologic behaviour of recurrence and malignant transformation.
format Text
id pubmed-2567991
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25679912008-10-16 Nuclear hBD-1 accumulation in malignant salivary gland tumours Wenghoefer, M Pantelis, A Dommisch, H Götz, W Reich, R Bergé, S Martini, M Allam, JP Jepsen, S Merkelbach-Bruse, S Fischer, HP Novak, N Winter, J BMC Cancer Research Article BACKGROUND: Whereas the antimicrobial peptides hBD-2 and -3 are related to inflammation, the constitutively expressed hBD-1 might function as 8p tumour suppressor gene and thus play a key role in control of transcription and induction of apoptosis in malignant epithelial tumours. Therefore this study was conducted to characterise proteins involved in cell cycle control and host defence in different benign and malignant salivary gland tumours in comparison with healthy salivary gland tissue. METHODS: 21 paraffin-embedded tissue samples of benign (n = 7), and malignant (n = 7) salivary gland tumours as well as healthy (n = 7) salivary glands were examined immunohistochemically for the expression of p53, bcl-2, and hBD-1, -2, -3. RESULTS: HBD-1 was distributed in the cytoplasm of healthy salivary glands and benign salivary gland tumours but seems to migrate into the nucleus of malignant salivary gland tumours. Pleomorphic adenomas showed cytoplasmic as well as weak nuclear hBD-1 staining. CONCLUSION: HBD-1, 2 and 3 are traceable in healthy salivary gland tissue as well as in benign and malignant salivary gland tumours. As hBD-1 is shifted from the cytoplasm to the nucleus in malignant salivary gland tumours, we hypothesize that it might play a role in the oncogenesis of these tumours. In pleomorphic adenomas hBD-1 might be connected to their biologic behaviour of recurrence and malignant transformation. BioMed Central 2008-10-07 /pmc/articles/PMC2567991/ /pubmed/18840281 http://dx.doi.org/10.1186/1471-2407-8-290 Text en Copyright © 2008 Wenghoefer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wenghoefer, M
Pantelis, A
Dommisch, H
Götz, W
Reich, R
Bergé, S
Martini, M
Allam, JP
Jepsen, S
Merkelbach-Bruse, S
Fischer, HP
Novak, N
Winter, J
Nuclear hBD-1 accumulation in malignant salivary gland tumours
title Nuclear hBD-1 accumulation in malignant salivary gland tumours
title_full Nuclear hBD-1 accumulation in malignant salivary gland tumours
title_fullStr Nuclear hBD-1 accumulation in malignant salivary gland tumours
title_full_unstemmed Nuclear hBD-1 accumulation in malignant salivary gland tumours
title_short Nuclear hBD-1 accumulation in malignant salivary gland tumours
title_sort nuclear hbd-1 accumulation in malignant salivary gland tumours
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2567991/
https://www.ncbi.nlm.nih.gov/pubmed/18840281
http://dx.doi.org/10.1186/1471-2407-8-290
work_keys_str_mv AT wenghoeferm nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT pantelisa nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT dommischh nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT gotzw nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT reichr nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT berges nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT martinim nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT allamjp nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT jepsens nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT merkelbachbruses nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT fischerhp nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT novakn nuclearhbd1accumulationinmalignantsalivaryglandtumours
AT winterj nuclearhbd1accumulationinmalignantsalivaryglandtumours